Literature DB >> 466049

The effect of levamisole on postoperative immunosuppression.

R Windle, R F Wood, P R Bell.   

Abstract

Cell mediated immunity was studied before and after surgery in patients with colorectal cancer. Thymus-derived (T) lymphocytes were enumerated and their non-specific activity was measured by assessing phytohaemagglutinin (PHA)-induced blastogenesis. Specific T lymphocyte activity was measured by leucocyte migration inhibition in response to purified protein derivative of tuberculin (PPD) and autochthonous tumour extract. One group of patients received levamisole postoperatively and the other group consisted of controls. There was a more rapid return to preoperative levels of leucocyte migration inhibition to both antigens by the levamisole group. However, levamisole administration had only a marginal effect on the postoperative depression of cell counts and did not restore depressed lymphoblast transformation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466049     DOI: 10.1002/bjs.1800660717

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant.

Authors:  E E Abdalla; I J Adam; G E Blair; A Boylston; H M Sue-Ling; P Finan; D Johnston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

2.  Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.

Authors:  S Miyazaki; T Akiyoshi; S Arinaga; F Koba; T Wada; H Tsuji
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

3.  Post operative stimulation of cell mediated immunity.

Authors:  J A Smith; W S Hendry; J L Duncan; J N Norman
Journal:  Klin Wochenschr       Date:  1985-10-01

4.  Depression of the generation of cell-mediated cytotoxicity after surgery.

Authors:  S Miyazaki; T Akiyoshi; S Arinaga; F Koba; H Tsuji
Journal:  Jpn J Surg       Date:  1983-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.